The United Kingdom has fallen to the bottom of the Group of Seven nations in total investment levels, recording a combined public and private investment rate of just 18.6 per
The United Kingdom has fallen to the bottom of the Group of Seven nations in total investment levels, recording a combined public and private investment rate of just 18.6 per
Britain recorded the weakest investment levels among G7 economies during the third quarter of 2025, with total public and private investment reaching merely 18.6 per cent of gross domestic product.
Revolut has announced plans to invest £3 billion in the United Kingdom over the next five years, as the fintech leader intensifies its pursuit of a full banking licence. Chief
Sir Jim Ratcliffe’s Ineos group has halted fresh investment in the United Kingdom and shifted its financial priorities to the United States, citing soaring energy costs and an unpredictable British
The potential departure of AstraZeneca from the London Stock Exchange would deliver a ‘devastating blow’ to British markets, former Chancellor Lord Lamont warned Parliament today. The Conservative peer emphasised that
The chief executive of Britain’s state economic development agency has issued a stark warning to UK pension funds, emphasising they risk overlooding a significant “goldmine of opportunity” within private British
In a significant move that underscores confidence in the UK financial sector, European insurance giant Athora has announced its acquisition of Pension Insurance Corporation (PIC) for £5.7 billion, marking the
US private equity giant KKR has emerged victorious in a heated takeover battle for British instrumentation specialist Spectris, securing a £4.1 billion all-cash deal that highlights the persistent undervaluation of
In a significant move that underscores its commitment to the British market, Amazon has unveiled plans to invest £40 billion in the UK over the next three years. The e-commerce
Investment in Britain’s vital life sciences sector is under threat due to a deteriorating commercial environment. Senior executives from major pharmaceutical companies, including Johnson & Johnson, are voicing concerns that
A nuclear power developer backed by Amazon has issued a stark warning about potentially withdrawing its UK investment plans unless the government provides clear regulatory and financial frameworks. X-Energy, headquartered
British pharmaceutical giant AstraZeneca has abandoned its £450 million expansion plans for its vaccine manufacturing facility in Speke, Liverpool, delivering a significant blow to the UK’s life sciences sector. The
David Lloyd Leisure, the premium health and wellness group, is revolutionising its club offerings with a substantial £500 million investment programme aimed at elevating its market position and differentiating itself
The fate of AstraZeneca’s planned £450 million investment in a vaccine manufacturing facility in northwest England hangs in the balance as the Treasury, under the leadership of Chancellor Rachel Reeves,






